Copyright Reports & Markets. All rights reserved.

Global Rapid Antigen Testing Market Size, Status and Forecast 2021-2027

Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Rapid Antigen Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Immunosorbent Assay
    • 1.2.3 Enzyme-linked Immunosorbent
    • 1.2.4 Precipitation Reaction
    • 1.2.5 Radioimmunoassay
    • 1.2.6 Agglutination Reaction
    • 1.2.7 Complement Fixatio
  • 1.3 Market by Application
    • 1.3.1 Global Rapid Antigen Testing Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospitals
    • 1.3.3 Specialty Clinics
    • 1.3.4 Diagnostic Centers
    • 1.3.5 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Rapid Antigen Testing Market Perspective (2016-2027)
  • 2.2 Rapid Antigen Testing Growth Trends by Regions
    • 2.2.1 Rapid Antigen Testing Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Rapid Antigen Testing Historic Market Share by Regions (2016-2021)
    • 2.2.3 Rapid Antigen Testing Forecasted Market Size by Regions (2022-2027)
  • 2.3 Rapid Antigen Testing Industry Dynamic
    • 2.3.1 Rapid Antigen Testing Market Trends
    • 2.3.2 Rapid Antigen Testing Market Drivers
    • 2.3.3 Rapid Antigen Testing Market Challenges
    • 2.3.4 Rapid Antigen Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Rapid Antigen Testing Players by Revenue
    • 3.1.1 Global Top Rapid Antigen Testing Players by Revenue (2016-2021)
    • 3.1.2 Global Rapid Antigen Testing Revenue Market Share by Players (2016-2021)
  • 3.2 Global Rapid Antigen Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Rapid Antigen Testing Revenue
  • 3.4 Global Rapid Antigen Testing Market Concentration Ratio
    • 3.4.1 Global Rapid Antigen Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Rapid Antigen Testing Revenue in 2020
  • 3.5 Rapid Antigen Testing Key Players Head office and Area Served
  • 3.6 Key Players Rapid Antigen Testing Product Solution and Service
  • 3.7 Date of Enter into Rapid Antigen Testing Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Rapid Antigen Testing Breakdown Data by Type

  • 4.1 Global Rapid Antigen Testing Historic Market Size by Type (2016-2021)
  • 4.2 Global Rapid Antigen Testing Forecasted Market Size by Type (2022-2027)

5 Rapid Antigen Testing Breakdown Data by Application

  • 5.1 Global Rapid Antigen Testing Historic Market Size by Application (2016-2021)
  • 5.2 Global Rapid Antigen Testing Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Rapid Antigen Testing Market Size (2016-2027)
  • 6.2 North America Rapid Antigen Testing Market Size by Type
    • 6.2.1 North America Rapid Antigen Testing Market Size by Type (2016-2021)
    • 6.2.2 North America Rapid Antigen Testing Market Size by Type (2022-2027)
    • 6.2.3 North America Rapid Antigen Testing Market Size by Type (2016-2027)
  • 6.3 North America Rapid Antigen Testing Market Size by Application
    • 6.3.1 North America Rapid Antigen Testing Market Size by Application (2016-2021)
    • 6.3.2 North America Rapid Antigen Testing Market Size by Application (2022-2027)
    • 6.3.3 North America Rapid Antigen Testing Market Size by Application (2016-2027)
  • 6.4 North America Rapid Antigen Testing Market Size by Country
    • 6.4.1 North America Rapid Antigen Testing Market Size by Country (2016-2021)
    • 6.4.2 North America Rapid Antigen Testing Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Rapid Antigen Testing Market Size (2016-2027)
  • 7.2 Europe Rapid Antigen Testing Market Size by Type
    • 7.2.1 Europe Rapid Antigen Testing Market Size by Type (2016-2021)
    • 7.2.2 Europe Rapid Antigen Testing Market Size by Type (2022-2027)
    • 7.2.3 Europe Rapid Antigen Testing Market Size by Type (2016-2027)
  • 7.3 Europe Rapid Antigen Testing Market Size by Application
    • 7.3.1 Europe Rapid Antigen Testing Market Size by Application (2016-2021)
    • 7.3.2 Europe Rapid Antigen Testing Market Size by Application (2022-2027)
    • 7.3.3 Europe Rapid Antigen Testing Market Size by Application (2016-2027)
  • 7.4 Europe Rapid Antigen Testing Market Size by Country
    • 7.4.1 Europe Rapid Antigen Testing Market Size by Country (2016-2021)
    • 7.4.2 Europe Rapid Antigen Testing Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Rapid Antigen Testing Market Size (2016-2027)
  • 8.2 Asia-Pacific Rapid Antigen Testing Market Size by Type
    • 8.2.1 Asia-Pacific Rapid Antigen Testing Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Rapid Antigen Testing Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Rapid Antigen Testing Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Rapid Antigen Testing Market Size by Application
    • 8.3.1 Asia-Pacific Rapid Antigen Testing Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Rapid Antigen Testing Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Rapid Antigen Testing Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Rapid Antigen Testing Market Size by Region
    • 8.4.1 Asia-Pacific Rapid Antigen Testing Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Rapid Antigen Testing Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Rapid Antigen Testing Market Size (2016-2027)
  • 9.2 Latin America Rapid Antigen Testing Market Size by Type
    • 9.2.1 Latin America Rapid Antigen Testing Market Size by Type (2016-2021)
    • 9.2.2 Latin America Rapid Antigen Testing Market Size by Type (2022-2027)
    • 9.2.3 Latin America Rapid Antigen Testing Market Size by Type (2016-2027)
  • 9.3 Latin America Rapid Antigen Testing Market Size by Application
    • 9.3.1 Latin America Rapid Antigen Testing Market Size by Application (2016-2021)
    • 9.3.2 Latin America Rapid Antigen Testing Market Size by Application (2022-2027)
    • 9.3.3 Latin America Rapid Antigen Testing Market Size by Application (2016-2027)
  • 9.4 Latin America Rapid Antigen Testing Market Size by Country
    • 9.4.1 Latin America Rapid Antigen Testing Market Size by Country (2016-2021)
    • 9.4.2 Latin America Rapid Antigen Testing Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Rapid Antigen Testing Market Size (2016-2027)
  • 10.2 Middle East & Africa Rapid Antigen Testing Market Size by Type
    • 10.2.1 Middle East & Africa Rapid Antigen Testing Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Rapid Antigen Testing Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Rapid Antigen Testing Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Rapid Antigen Testing Market Size by Application
    • 10.3.1 Middle East & Africa Rapid Antigen Testing Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Rapid Antigen Testing Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Rapid Antigen Testing Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Rapid Antigen Testing Market Size by Country
    • 10.4.1 Middle East & Africa Rapid Antigen Testing Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Rapid Antigen Testing Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Abbott Laboratories
    • 11.1.1 Abbott Laboratories Company Details
    • 11.1.2 Abbott Laboratories Business Overview
    • 11.1.3 Abbott Laboratories Rapid Antigen Testing Introduction
    • 11.1.4 Abbott Laboratories Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.1.5 Abbott Laboratories Recent Development
  • 11.2 F. Hoffmann-La Roche
    • 11.2.1 F. Hoffmann-La Roche Company Details
    • 11.2.2 F. Hoffmann-La Roche Business Overview
    • 11.2.3 F. Hoffmann-La Roche Rapid Antigen Testing Introduction
    • 11.2.4 F. Hoffmann-La Roche Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.2.5 F. Hoffmann-La Roche Recent Development
  • 11.3 Oxford BioMedica
    • 11.3.1 Oxford BioMedica Company Details
    • 11.3.2 Oxford BioMedica Business Overview
    • 11.3.3 Oxford BioMedica Rapid Antigen Testing Introduction
    • 11.3.4 Oxford BioMedica Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.3.5 Oxford BioMedica Recent Development
  • 11.4 Affinity Biologicals
    • 11.4.1 Affinity Biologicals Company Details
    • 11.4.2 Affinity Biologicals Business Overview
    • 11.4.3 Affinity Biologicals Rapid Antigen Testing Introduction
    • 11.4.4 Affinity Biologicals Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.4.5 Affinity Biologicals Recent Development
  • 11.5 Epitope Diagnostics
    • 11.5.1 Epitope Diagnostics Company Details
    • 11.5.2 Epitope Diagnostics Business Overview
    • 11.5.3 Epitope Diagnostics Rapid Antigen Testing Introduction
    • 11.5.4 Epitope Diagnostics Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.5.5 Epitope Diagnostics Recent Development
  • 11.6 Sino Biological
    • 11.6.1 Sino Biological Company Details
    • 11.6.2 Sino Biological Business Overview
    • 11.6.3 Sino Biological Rapid Antigen Testing Introduction
    • 11.6.4 Sino Biological Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.6.5 Sino Biological Recent Development
  • 11.7 R-Biopharma
    • 11.7.1 R-Biopharma Company Details
    • 11.7.2 R-Biopharma Business Overview
    • 11.7.3 R-Biopharma Rapid Antigen Testing Introduction
    • 11.7.4 R-Biopharma Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.7.5 R-Biopharma Recent Development
  • 11.8 Cell Biolabs
    • 11.8.1 Cell Biolabs Company Details
    • 11.8.2 Cell Biolabs Business Overview
    • 11.8.3 Cell Biolabs Rapid Antigen Testing Introduction
    • 11.8.4 Cell Biolabs Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.8.5 Cell Biolabs Recent Development
  • 11.9 Thermo Fisher Scientific
    • 11.9.1 Thermo Fisher Scientific Company Details
    • 11.9.2 Thermo Fisher Scientific Business Overview
    • 11.9.3 Thermo Fisher Scientific Rapid Antigen Testing Introduction
    • 11.9.4 Thermo Fisher Scientific Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.9.5 Thermo Fisher Scientific Recent Development
  • 11.10 Bio-Rad Laboratories
    • 11.10.1 Bio-Rad Laboratories Company Details
    • 11.10.2 Bio-Rad Laboratories Business Overview
    • 11.10.3 Bio-Rad Laboratories Rapid Antigen Testing Introduction
    • 11.10.4 Bio-Rad Laboratories Revenue in Rapid Antigen Testing Business (2016-2021)
    • 11.10.5 Bio-Rad Laboratories Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Rapid Antigen Testing Scope and Market Size
    Rapid Antigen Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Rapid Antigen Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Immunosorbent Assay
    Enzyme-linked Immunosorbent
    Precipitation Reaction
    Radioimmunoassay
    Agglutination Reaction
    Complement Fixatio

    Segment by Application
    Hospitals
    Specialty Clinics
    Diagnostic Centers
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Abbott Laboratories
    F. Hoffmann-La Roche
    Oxford BioMedica
    Affinity Biologicals
    Epitope Diagnostics
    Sino Biological
    R-Biopharma
    Cell Biolabs
    Thermo Fisher Scientific
    Bio-Rad Laboratories

    Buy now